Press monitoring
Consumers See Advantages in Food Developed With Biotechnology, Says Survey
5.1.2006 | Press monitoring
Two-thirds of consumers would buy biotech food made from crops that required less spraying. A majority of U.S. consumers would likely buy food developed using biotechnology that tastes better or fresher or was made from crops that required less pesticide spraying, according to a new survey by the International Food Information Council...
Biotech crops mark first decade with wins and losses
5.1.2006 | Press monitoring
When Monsanto introduced the world to genetically modified crops a decade ago, the biotech advancement was heralded as the dawn of a new era that could reduce world hunger, help the environment and bolster struggling farmers.
New Study Published in PNAS Confirms Potential Utility of Marillion´s Nanoparticle Technology for Tumor Targeting Agents
5.1.2006 | Press monitoring
Marillion Pharmaceuticals, an emerging biotechnology company developing cancer therapeutics, announced that the science underlying its core technology was published in the "Proceedings of the National Academy of Sciences" (PNAS).
The benefits of biotechnology
5.1.2006 | Press monitoring
For centuries, aboriginal peoples have known the aspirin-like compound found in the bark of willow tree would ease pain. More recently, a random deposit of a fungus spore on a bacterial culture started Sir Alexander Fleming on the road to discovering penicillin.
A Shot to Stop Diabetes in Mice - Intervention in Immune Regulation Can Prevent Onset of Type-1 Diabetes
5.1.2006 | Press monitoring
Some forms of diabetes could feasibly be prevented. Scientists at the German Research Centre for Biotechnology (GBF) in Braunschweig recently were able to do just that in experiments with mice. Animals with a congenital susceptibility for Type-1 diabetes remained healthy when researchers treated them with an immune regulator shortly after birth....
Papillomaviruses as targets for cancer gene therapy
4.1.2006 | Press monitoring
The human papillomaviruses (HPVs) are a diverse group of infectious agents, some of which are a causative agent of human cancers. Cervical cancer and oral cancer are closely associated with specific types of HPV, and the tumors grow only if there is continual expression of the viral E6 and E7 genes.
Researchers Identify A New Class Of Anti-cancer Drugs Based On Platinum
4.1.2006 | Press monitoring
Researchers at Virginia Commonwealth University's Massey Cancer Center have created a new platinum-based, anti-cancer agent able to overcome acquired drug resistance by first modifying the way it is absorbed into cancer cells and then attacking the DNA of those cancer cells.
Germany Starts Sowing GM Seeds
4.1.2006 | Press monitoring
In a sharp departure from existing policy, Germany's new agriculture minister is promoting genetically modified technology instead of organic farming. Now, the first three types of GM corn have received approval.
Rapid and effective diagnosis of infectious diseases
23.12.2005 | Press monitoring
The EU funded Optolab Card project is developing and mass producing a miniaturised optical laboratory on a card, allowing bacterial infectious diseases to be diagnosed in just 15 minutes. The new device is expected to reach the market in six years.
BrainStorm`s Stem Cells Benefit Parkinson`s
23.12.2005 | Press monitoring
BrainStorm Cell Therapeutics has successfully implanted human bone marrow derived stem cells into animal models of Parkinson`s disease and observed improved motor function within just two weeks of implantation. The beneficial effect was retained for over three months.
